430 related articles for article (PubMed ID: 37408838)
1. The gut-liver axis in immune remodeling of hepatic cirrhosis.
Guan H; Zhang X; Kuang M; Yu J
Front Immunol; 2022; 13():946628. PubMed ID: 37408838
[TBL] [Abstract][Full Text] [Related]
2. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
3. Microbiota, cirrhosis, and the emerging oral-gut-liver axis.
Acharya C; Sahingur SE; Bajaj JS
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978799
[TBL] [Abstract][Full Text] [Related]
4. Gut-liver axis signaling in portal hypertension.
Simbrunner B; Mandorfer M; Trauner M; Reiberger T
World J Gastroenterol; 2019 Oct; 25(39):5897-5917. PubMed ID: 31660028
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
6. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of microbiome in patients with decompensated cirrhosis.
Oikonomou T; Papatheodoridis GV; Samarkos M; Goulis I; Cholongitas E
World J Gastroenterol; 2018 Sep; 24(34):3813-3820. PubMed ID: 30228776
[TBL] [Abstract][Full Text] [Related]
8. The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases.
Yang X; Lu D; Zhuo J; Lin Z; Yang M; Xu X
Int J Biol Sci; 2020; 16(13):2357-2366. PubMed ID: 32760203
[TBL] [Abstract][Full Text] [Related]
9. Gut-liver axis: Pathophysiological concepts and clinical implications.
Tilg H; Adolph TE; Trauner M
Cell Metab; 2022 Nov; 34(11):1700-1718. PubMed ID: 36208625
[TBL] [Abstract][Full Text] [Related]
10. Modulating the gut-liver axis and the pivotal role of the faecal microbiome in cirrhosis.
Woodhouse C; Singanayagam A; Patel VC
Clin Med (Lond); 2020 Sep; 20(5):493-500. PubMed ID: 32934044
[TBL] [Abstract][Full Text] [Related]
11. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy
Luo M; Xin RJ; Hu FR; Yao L; Hu SJ; Bai FH
World J Gastroenterol; 2023 Jan; 29(1):144-156. PubMed ID: 36683714
[TBL] [Abstract][Full Text] [Related]
12. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
13. Targeting the gut-liver-immune axis to treat cirrhosis.
Tranah TH; Edwards LA; Schnabl B; Shawcross DL
Gut; 2021 May; 70(5):982-994. PubMed ID: 33060124
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis.
Maslennikov R; Poluektova E; Zolnikova O; Sedova A; Kurbatova A; Shulpekova Y; Dzhakhaya N; Kardasheva S; Nadinskaia M; Bueverova E; Nechaev V; Karchevskaya A; Ivashkin V
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003692
[TBL] [Abstract][Full Text] [Related]
15. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease.
Maccioni L; Leclercq IA; Schnabl B; Stärkel P
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884492
[TBL] [Abstract][Full Text] [Related]
16. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
[TBL] [Abstract][Full Text] [Related]
17. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
18. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
Jiang JW; Chen XH; Ren Z; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
[TBL] [Abstract][Full Text] [Related]
19. Altered Microbiome in Patients With Cirrhosis and Complications.
Acharya C; Bajaj JS
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):307-321. PubMed ID: 30099098
[TBL] [Abstract][Full Text] [Related]
20. Liver cirrhosis and immune dysfunction.
Hasa E; Hartmann P; Schnabl B
Int Immunol; 2022 Sep; 34(9):455-466. PubMed ID: 35792761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]